Gilead Sciences, Inc. (GILD)
136.30
+2.82
(+2.11%)
USD |
NASDAQ |
May 06, 16:00
136.40
+0.10
(+0.07%)
Pre-Market: 08:27
Gilead Sciences Free Cash Flow : 9.456B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.597B |
| Biogen, Inc. | 2.316B |
| Johnson & Johnson | 17.80B |
| Arcellx, Inc. | -212.58M |
| Moderna, Inc. | -1.603B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.327B |
| Cash from Investing (Quarterly) | -1.835B |
| Cash from Financing (Quarterly) | -1.263B |
| Free Cash Flow Per Share (Quarterly) | 2.492 |
| Free Cash Flow to Equity (Quarterly) | 2.522B |
| Free Cash Flow to Firm (Quarterly) | 3.390B |
| Free Cash Flow Yield | 5.53% |